Head and Neck Cancers Coverage from Every Angle
Advertisement
Advertisement

Lara Dunn, MD, on Managing Immunotherapy Adverse Events in Head and Neck Cancer

Posted: Friday, May 31, 2019

What clinical pearls can you share to limit the adverse events associated with immunotherapy for head and neck cancer?

Advertisement
Advertisement


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.